Matthew J. Silveira (Matt)

Partner

San Francisco + 1.415.875.5715

Connect

Share

Matt Silveira has been litigating for nearly 20 years. A member of Jones Day's Issues & Appeals Practice, he spends as much time leading motion practice and legal strategy in complex trial court litigation as he does handling appeals and writs.

Matt's experience crosses industries and practice areas. He has represented clients in the technology, life sciences, health care, hospitality, construction, retail, and financial services industries in matters involving antitrust, patents, trade secrets, copyright, employment, contracts, real property, administrative law, and false claims. In addition to having significant experience in California courts, Matt has argued appeals and dispositive motions in state and federal courts across the nation, including the Ninth Circuit, Federal Circuit, and D.C. Circuit.

Matt also maintains a varied pro bono practice, including representing civil rights plaintiffs in the federal courts and immigration clients in proceedings before the Ninth Circuit and the Board of Immigration Appeals.

Erfahrung

  • Merck's BRIDION® Hatch-Waxman trial victory on patent term extension issue affirmed at CAFCJones Day represented Merck Sharp & Dohme, B.V. in Hatch-Waxman patent infringement actions originally filed against 16 generic drug maker defendant groups, relating to the defendant groups' Abbreviated New Drug Applications (ANDA) seeking approval of generic versions of BRIDION®, a first-in-class agent for the reversal of certain types of neuromuscular blockade in adults undergoing surgery.
  • Ecolab victorious at arbitration and appeal against individual and California-wide wage and hour PAGA claimsFollowing a four-day arbitration hearing, Jones Day won a second judgment in Ecolab Inc.'s favor in a California Labor Code Private Attorneys General Act ("PAGA") case filed by a repeat plaintiff seeking penalties on behalf of employees statewide.
  • Chemtronics resolves patent infringement claims involving touch screen technologyJones Day represented Chemtronics Co., Ltd. against a competitor in a patent infringement case in the Eastern District of Texas.
  • Leader in residential mortgage industry wins full dismissal with prejudice of employee solicitation and theft of confidential information allegationsThe Jones Day team won a complete victory for a leader in the residential mortgage industry in a case filed by a competitor.
  • California Hospital Association wins summary judgment in labor law and health care caseJones Day secured a major win for the California Hospital Association (CHA) in a matter that has significant ramifications for labor law and the health care industry.
  • NXP defends multi-jurisdiction patent infringement suits involving RFID technologyJones Day represented NXP USA Inc. against a competitor in a global patent infringement dispute involving more than 50 patents.
  • Micron Technology asserts trade secret and RICO claims, establishes U.S. jurisdiction over foreign defendants under DTSAJones Day represented Micron Technology, Inc. as a plaintiff in a trade secret and RICO lawsuit against Taiwanese and Chinese entities accused of theft of Micron's semiconductor processing technology.
  • Global financial institution defends claims in VRDO mattersJones Day is defending a global financial institution in several matters related to its activities as remarketing agent for variable rate demand obligations (“VRDOs”) issued by agencies or units of state and local government.
  • Sutter Health wins complete defense verdict in landmark antitrust class actionJones Day won a complete defense jury verdict for Sutter Health in a landmark antitrust class action seeking $1.2 billion in treble damages.
  • HDR Global Trading obtains dismissal with prejudice in 33-count lawsuitJones Day client HDR Global Trading Limited ("HDR"), the Seychelles-incorporated owner and operator of the BitMEX cryptocurrency derivatives trading platform, obtained dismissal with prejudice of a 33-count lawsuit alleging violations of the Commodity Exchange Act, RICO, and various California statutory and common law claims.
  • Large regional property manager sells $1 billion portfolio of 27 multifamily propertiesJones Day represented a large regional property manager in its $1 billion sale of a portfolio of 27 multifamily properties consisting of over 500 buildings and close to 8,000 units.
  • PI Advanced Materials obtains CAFC affirmance of summary judgment win in patent case regarding polyimide filmsJones Day successfully obtained a Federal Circuit affirmance of a summary judgment win of non-infringement on behalf of PI Advanced Materials Co., Ltd. ("PIAM", formerly SKC Kolon PI, Inc. ("SKPI")).
  • Xilinx defends against patent claims by Japanese sovereign patent fund IP BridgeJones Day represented Xilinx Inc., the industry leader in field programmable gate arrays, in its patent dispute with Godo Kaisha IP Bridge 1 ("IP Bridge"), a Japanese sovereign patent fund that holds approximately 800 patents and attempts to generate revenues by enforcing patents against U.S. operating companies.
  • Sherwin-Williams defends lead paint actions brought by California cities and countiesJones Day is defending The Sherwin-Williams Company against claims brought by ten of California's largest cities and counties.
  • Adocia prevails in biopharma license agreement dispute in international arbitrationJones Day won a binding arbitration award for French biopharmaceutical company, Adocia S.A., in a license agreement dispute against Eli Lilly and Company.
  • HP obtains writ of mandamus in patent litigationOn behalf of HP Inc., Jones Day obtained a rare writ of mandamus from the Federal Circuit ordering Judge Schroeder from the Eastern District of Texas to transfer a patent litigation involving Google Chrome products to the Northern District of California.
  • Synopsys reaches agreement with Mentor Graphics in competitor patent caseJones Day served as lead trial counsel for Synopsys Inc. in competitor patent litigation against Mentor Graphics Corporation following the Federal Circuit’s remand of the case to the district court.
  • H&R Block defeats patent infringement case brought by UnilocJones Day successfully defended H&R Block, Inc. in a multi-patent infringement lawsuit brought by Uniloc USA, Inc.
  • Xilinx proves unpatentability of third party patent claims in USPTO IPR and at Federal CircuitJones Day successfully represented Xilinx, Inc. in defending patent claims asserted by PLL Technologies, Inc. in the District of Delaware as well as before the Patent Trial and Appeal Board (PTAB) in an inter partes review (IPR) challenge to the patent and on the subsequent appeal to the Federal Circuit.
  • Xilinx obtains Federal Circuit decisions affirming dismissal under Alice and setting personal jurisdiction precedentJones Day represented Xilinx, Inc. in multiple venues against patent infringement assertions relating to integrated circuit testing technology.
    •

    May 2024 Commentary

    California Supreme Court Will Review Novel Negligence Theory for Pharmaceutical Manufacturers

    February 2024 Blog

    Federal Circuit Affirms Claim Construction and How It Applies, PTAB Litigation Blog

    October 2021

    Ninth Circuit Affirms Standing to Bring Securities Act Claims in Connection With Direct Listing Despite Tracing Difficulties

    JULY 2021 Alert

    D.C. Circuit Holds International Finance Corporation Immune From Suit in Lender Liability Action

    November 2019 Blog

    Alice at Five, PTAB Litigation Blog

    March 2017 Commentary

    Decision Cheered by Some, as Supreme Court Clarifies Useful Articles Copyright Protection

    August 2015 Alert

    Federal Circuit's Unanimous En Banc Decision Focuses on "Attribution to a Single Entity" to Establish Divided-Infringement Liability

    June 2015 External Publications

    What To Expect From The 9th Circuit In RAND Case, Law360

    May 2015 Alert

    Divided Federal Circuit Panel Stands by the Single Entity Rule for Direct Patent Infringement

    April 2015 Jones Day Publications

    Claim Construction, Findings of Fact, and Indefiniteness in the Wake of Teva v. Sandoz
    Weitere Veröffentlichungen

    Bitte beachten Sie vor dem Versenden:

    Die Informationen auf unserer Website sind für den allgemeinen Gebrauch und stellen keine Rechtsberatung dar. Der Versand dieser E-Mail ist nicht dazu bestimmt, ein Mandatsverhältnis zu begründen, und der Erhalt dieser E-Mail stellt kein Mandatsverhältnis dar. Alles, was Sie an jemanden in unserer Kanzlei senden, ist nicht vertraulich oder privilegiert, es sei denn, wir haben zugestimmt, Sie zu vertreten. Wenn Sie diese E-Mail versenden, bestätigen Sie, dass Sie diesen Hinweis gelesen und verstanden haben.